Breaking News

DMC Biotechnologies completes downstream processing for L-alanine

The purification of L-alanine from the fermentation broth was completed for more than 6,000 kg of product

Catalent acquires third facility in Belgium for pDNA manufacturing

CDMO Catalent has acquired liver disease specialist Promethera's cell therapy manufacturing subsidiary, including its ...

BioVaxys and BioElpida agree to begin ovarian cancer vaccine bioproduction

The two companies have signed the new definitive agreement focusing on the GMP facility build-out in Lyon, and ...

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part III)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

German CDMO to spend $84m expanding biological cGMP space

Richter-Helm BioLogics has received investment for the new multi-product biological manufacturing facility that is ...

Lonza to double drug substance production for Moderna vaccine

In May 2020, the companies announced a 10-year agreement to enable the manufacture of the COVID-19 vaccine and ...

Taking a lifecycle approach to fill-finish success

Dr Kevin Robinson recently spoke to swissfillon founder and CEO, Daniel Kehl, and Business Development Director, Carole ...

Asher contracts ProBioGen to develop lead candidate

ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology, applying its transposase ...

AavantiBio and Catalent announce partnership

Catalent will support the development and manufacturing of AavantiBio’s gene therapies for rare genetic diseases

The CMO RFQ process and expectation management

Managing expectations during a request for quotation (RFQ) process is a crucial part of establishing a trustful and ...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

DNA Script Partners with Moderna

The partnership will develop a prototype for the on-demand manufacturing of caccines and therapeutics for DARPA

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle